Cargando…
Structurally Modified Bioactive Peptide Inhibits SARS-CoV-2 Lentiviral Particles Expression
Coronavirus disease 2019 (COVID-19), the current global pandemic is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Various pharmaceuticals are being developed to counter the spread of the virus. The strategy of repurposing known drugs and bioactive molecules is a rational ap...
Autores principales: | Bhullar, Khushwant S., Nael, Manal A., Elokely, Khaled M., Drews, Steven J., Wu, Jianping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607082/ https://www.ncbi.nlm.nih.gov/pubmed/36297481 http://dx.doi.org/10.3390/pharmaceutics14102045 |
Ejemplares similares
-
Translating bioactive peptides for COVID-19 therapy
por: Bhullar, Khushwant S., et al.
Publicado: (2021) -
Spent Hen Muscle Protein-Derived RAS Regulating Peptides Show Antioxidant Activity in Vascular Cells
por: Fan, Hongbing, et al.
Publicado: (2021) -
Peptides GWN and GW protect kidney cells against Dasatinib induced mitochondrial injury in a SIRT1 dependent manner
por: Bhullar, Khushwant S., et al.
Publicado: (2021) -
Tripeptide IRW Protects MC3T3-E1 Cells against Ang II Stress in an AT2R Dependent Manner
por: Shang, Nan, et al.
Publicado: (2022) -
The Effect of Polyphenols on Kidney Disease: Targeting Mitochondria
por: Ashkar, Fatemeh, et al.
Publicado: (2022)